Medical Specialists Associates - Procalcitonin in Antibiotic Stewardship: A Comprehensive Guide by Christopher Voss, MD, MS board-certified in anesthesiology, critical care, and neurocritical care medicine.
References:
1. Schuetz P, ChristCrain M, Thomann R, et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: The ProHOSP randomized controlled trial. JAMA. 2009;302(10):10591066.
2. Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomized controlled trial. Lancet. 2010;375(9713):463474.
3. de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, openlabel trial. Lancet Infect Dis. 2016;16(7):819827.
4. Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB. The diagnostic accuracy of procalcitonin for bacteraemia: A systematic review and metaanalysis. Clin Microbiol Infect. 2015;21(5):474481.
5. Simon L, Gauvin F, Amre DK, SaintLouis P, Lacroix J. Serum procalcitonin and Creactive protein levels as markers of bacterial infection: A systematic review and metaanalysis. Clin Infect Dis. 2004;39(2):206217.
6. Hattori T, Nishiyama H, Kato H, Ikeda T, Morita H. Clinical value of procalcitonin in patients with suspected bloodstream infection: can procalcitonin reduce the rate of blood culture contamination? Am J Clin Pathol. 2014;141(1):4351.
7 сен 2024
